BerGenBio (@BGenBio) header
BerGenBio (@BGenBio) profile picture

$BGBIO We are a clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL in aggressive diseases

Bergen, Norway / Oxford, UK
Joined December 2016
Photo by BerGenBio (@BGenBio)Photo by BerGenBio (@BGenBio)Photo by BerGenBio (@BGenBio)Photo by BerGenBio (@BGenBio)Photo by BerGenBio (@BGenBio)Photo by BerGenBio (@BGenBio)Photo by BerGenBio (@BGenBio)Photo by BerGenBio (@BGenBio)Photo by BerGenBio (@BGenBio)Photo by BerGenBio (@BGenBio)
BerGenBio retweeted
I morgen tar vi opp 2 podkaster: Den første med AdjuTec Pharma, oppstartselskap som ser etter investorer og så @BGenBio med CEO Richard Godfrey. Spørsmål tas i mot! #helsenæring
1
8
18
Read our Lighthouse note on @BGenBio at trinitydelta.org/companies/b…, which covers the company's H119 results and the refinements to the clinical programme for its lead asset bemcentinib, the selective AXL inhibitor.
2
3
Further Phase II proof-of-concept data was presented at #ASCO19, which support #bemcentinib’s potential in #NSCLC and #AML as a part of a combination regimen. Read our @BGenBio note at: trinitydelta.org/research-no…
2
5
More good news coming out of @OsloCancer from member @BGenBio nlsinsight.com/post/encourag… #Clinicaltrial #Immunotherapy
1
1
DNBs Nordic Healthcare Conference in Oslo is about to kick off. Follow #dnbhcc for updates bit.ly/dnbhcc16
Very cool. #ASH16 --> @ASH_hematology continued, creative, innovative ideas to engage all at meeting. #ASH16Art #HemeArt #Impact
2
1
10